Diagnosis and classification of autoimmune parathyroid disease

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 417-422

  Betterle, Corrado ^a   Garelli, Silvia ^a   Presotto, Fabio ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b OSPEDALE DELL'ANGELO   (Italy)

Author keywords

Autoimmune hypoparathyroidism; Autoimmune polyendocrine syndromes; Calcium sensing receptor autoantibodies; Chronic hypoparathyroidism; NACHT leucine rich repeat protein 5 autoantibodies

Indexed keywords

AUTOANTIBODY; CALCIUM; CALCIUM SENSING RECEPTOR AUTOANTIBODY; NACHT LEUCINE RICH REPEAT PROTEIN 5 AUTOANTIBOY; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNE PARATHYROID DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE MUTATION; HEART FAILURE; HORMONAL THERAPY; HUMAN; HYPOCALCEMIA; INCIDENCE; LARYNX SPASM; MUCOCUTANEOUS CANDIDIASIS; MULTIPLE ENDOCRINE ADENOMATOSIS; PARATHYROID DISEASE; PARATHYROID GLAND; PREVALENCE; REVIEW; TONIC CLONIC SEIZURE; VITAMIN SUPPLEMENTATION;

AUTOIMMUNE HYPOPARATHYROIDISM; AUTOIMMUNE POLYENDOCRINE SYNDROMES; CALCIUM-SENSING RECEPTOR AUTOANTIBODIES; CHRONIC HYPOPARATHYROIDISM; NACHT LEUCINE-RICH-REPEAT PROTEIN 5 AUTOANTIBODIES;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; HUMANS; HYPOPARATHYROIDISM; PARATHYROID GLANDS; RECEPTORS, CALCIUM-SENSING;

EID: 84896316514     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.044     Document Type: Review

References (52)

1. Liu S.H. A comparative study of the effects of various treatments on the calcium and phosphorus metabolism in tetany. II. Chronic adult idiopathic tetany. J Clin Invest 1928, 5:277-284.
2. Torpe E.S., Handley H.E. Chronic tetany and chronic mycelial stomatitis in a child aged 4 and half years. Am J Dis Child 1929, 38:328-338.
3. Sutphin A., Albright F., Mc Cune P.J. Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis. J Clin Endocrinol 1943, 3:625.
4. Bronsky D., Kushner D.S., Dubin A., Snapper I. Idiopathic hypoparathyroidism and pseudohypoparathyroidism. Case reports and review of the literature. Medicine 1958, 37:317.
5. McIntyre Gass J.D. The syndrome of keratoconjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison's disease. Am J Ophthalmol 1962, 54:660-674.
6. Witebsky E., Rose N.R., Terplan K., Paine J.R., Egan R.W. Chronic thyroiditis and autoimmunization. JAMA 1957, 164:1439-1447.
7. Lupulescu A., Pop A., Merculiev A., Neascu C., Heitmanek C. Experimental iso-immune hypoparathyroidism in rats. Nature 1965, 206:415-416.
8. Russel N.J., Bond K.A., Robertson I.D., Parry B.W., Irwin P.J. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases. Aust Vet J 2006, 84:285-290.
9. Krug J., Williams A.J.K., Beales P.E., Doniach I., Gale E.A.M., Pozzilli P. Parathyroiditis in the non obese diabetic mouse-a new finding. J Endocrinol 1991, 131:193-196.
10. Betterle C., Presotto F. Autoimmune polyendocrine syndromes (APS) or multiple autoimmune syndromes (MAS). Handbook of systemic autoimmune diseases, volume 9 endocrine manifestations of systemic autoimmune diseases 2008, 135-148. Elsevier B.V., Philadelphia. S. Walker, L.J. Jara (Eds.).
11. Alimohammadi M., Björklund P., Hallgren A., Pöntynen N., Szinnai G., Shikama N., et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 2008, 358:1018-1028.
12. Husebye E.S., Perheentupa J., Rautemaa R., Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 2009, 265:514-529.
13. Betterle C., Volpato M., Rees Smith B., Furmaniak J., Chen S., Zanchetta R., et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997, 82:939-942.
14. Goswami R., Brown E.M., Kochupillai N., Gupta N., Rani R., Kifor O., et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 2004, 150:9-18.
15. Goswami R., Singh A., Gupta N., Indian Genome Variation Consortium, Rani R. Presence of strong association of the major histocompatibility complex (MHC) class I allele HLA-A*26:01 with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 2012, 97:E1820-E1824.
16. Bilezikian J.P., Khan A., Potts J.T., Brandi M.L., Clarke B.L., Shoback D., et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011, 26:2317-2337.
17. De Sanctis V., Ashraf Soliman A., Fiscina B. Hypoparathyroidism: from diagnosis to treatment. Curr Opin Endocrinol Diabetes Obes 2012, 19:435-442.
18. Brandi M.L. Genetics of hypoparathyroidism and pseudohypoparathyroidism. J Endocrinol Invest 2011, 34:27-34.
19. Sarin R., Tomar N., Ray D., Gupta N., Dutta Sharma Y., Goswami R. Absence of pathogenic calcium sensing receptor mutations in sporadic idiopathic hypoparathyroidism. Clin Endocrinol 2006, 65:359-363.
20. Tomar N., Bora H., Singh R., Gupta N., Kaur P., Singh Chauhan S., et al. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members. Eur J Endocrinol 2010, 162:407-421.
21. Ahonen P., Myllarniemi S., Sipila I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990, 322:1829-1836.
22. Rosatelli M.C., Meloni A., Devoto M., Cao A., Scott H.S., Peterson P., et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998, 103:428-434.
23. Wolff A.S.B., Erichsen M.M., Meager A., Magitta N.F., Myhre A.G., Bollerslev J., et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007, 92:595-603.
24. Dominguez M., Crushell E., Ilmarinen T., McGovern E., Collins S., Chang B., et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab 2006, 19:1343-1352.
25. Sato K., Nakajima K., Imamura H., Deguchi T., Horinouchi S., Yamazaki K., et al. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocr J 2002, 49:625-633.
26. Zlotgora J., Cohen T. Idiopathic hypoparathyroidism in Israel. Isr J Med Sci 1981, 17:53-54.
27. Nakamura Y., Matsumoto T., Tamakoshi A., Kawamura T., Seino Y., Kasuga M., et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 2000, 10:29-33.
28. Levine M.A. Hypoparathyroidism and pseudohypoparathyroidism. Endocrinology volume 2 2001, 1611-1636. Elsevier B.V., Philadelphia. L.J. De Groot, L.J. Jameson (Eds.).
29. Bhadada S.K., Bhansali A., Upreti V., Subbiah S., Khandelwal N. Spectrum of neurological manifestations of idiopathic hypoparathyroidism and pseudohypoparathyroidism. Neurol India 2011, 59:586-589.
30. Mavroudis K., Aloumanis K., Stamatis P., Antonakoudis G., Kifnidis K., Antonakoudis C. Irreversible end-stage heart failure in a young patient due to severe chronic hypocalcemia associated with primary hypoparathyroidism and celiac disease. Clin Cardiol 2010, 33:E72-E75.
31. Goswami R., Sharma R., Sreenivas V., Gupta N., Ganapathy A., Das S. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol 2012, 77:200-206.
32. Blizzard R.M., Chee D., Davis W. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol 1966, 1:119-128.
33. Irvine W.J., Scarth L. Antibody to the oxyphil cells of the human parathyroid in idiopathic hypoparathyroidism. Clin Exp Immunol 1969, 4:505-510.
34. Swana G.T., Swana M.R., Bottazzo G.F., Doniach D. A human specific mitochondria antibody: its importance in the identification of organ-specific reactions. Clin Exp Immunol 1977, 28:517-525.
35. Betterle C., Caretto A., Zeviani M., Pedini B., Salviati G. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol 1985, 62:353-360.
36. Brandi M.L., Aurbach G.D., Fattorossi A., Quarto R., Marx S.J., Fitzpatrick L.A. Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci 1986, 83:8366-8369.
37. Fattorossi A., Aurbach G.D., Sakaguchi K. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci 1988, 85:4015-4019.
38. Li Y., Song Y.H., Rais N., Connor E., Schatz D., Muir A., et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996, 97:910-914.
39. Kemp E.H., Gavalas N.G., Akhtar S., Krohn K.J., Pallais J.C., Brown E.M., et al. Mapping of human autoantibody binding sites on the calcium-sensing receptor. J Bone Miner Res 2010, 25:132-140.
40. Kifor O., McElduff A., Leboff M.S., Moore F.D., Butters R., Gao P., et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 2004, 89:548-556.
41. Kemp E.H., Gavalas N.G., Krohn K.J., Brown E.M., Watson P.F., Weetman A.P. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2009, 94:4749-4756.
42. Kifor O., Moore F.D., Delaney M., Garber J., Hendy G.N., Butters R., et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium sensing receptor. J Clin Endocrinol Metab 2003, 88:60-72.
43. Pallais J.C., Kifor O., Chen Y.-B., Slovik D., Brown E.M. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium sensing receptor. N Eng J Med 2004, 351:362-369.
44. Makita N., Sato J., Manaka K., Shoji Y., Oishi A., Hashimoto M., et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci 2007, 104:5443-5448.
45. Tomar N., Gupta N., Goswami R. Calcium sensing receptor autoantibodies and idiopathic hypoparathyroidism. J Clin Endocrinol Metab 2013, 98:3884-3891.
46. Cervato S., Morlin L., Albergoni M.P., Masiero S., Greggio N., Meossi C., et al. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED. Clin Endocrinol 2010, 73:630-636.
47. Tomar N., Kaushal E., Das M., Gupta N., Betterle C., Goswami R. Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 2012, 97:1219-1226.
48. Shoback D. Hypoparathyroidism. N Engl J Med 2008, 359:391-403.
49. Mayer A., Ploix C., Orgiazzi J., Desbos A., Moreira A., Vidal H., et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab 2004, 89:4484-4488.
50. Gylling M., Kääriäinen E., Väisänen R., Kerosuo L., Solin M.L., Halme L., et al. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex. J Clin Endocrinol Metab 2003, 88:4602-4608.
51. Gavalas N.G., Kemp E.H., Krohn K.J., Brown E.M., Watson P.F., Weetman A.P. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2007, 92:2107-2114.
52. Soderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004, 89:557-562.